As IGFBP3, a well known protein, negatively regulates Akt activation (26, 27), it is possible that bufalin may regulate CRC cell proliferation via p53-IGFBP3-Akt-Aurora A/B pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.